In the first 11 months, the main board of Shanghai and Shenzhen issued 22 new shares to raise a total of about 20.2 billion yuan. Statistics show that from January to November 2024, there were 22 new shares listed on the main board of Shanghai and Shenzhen, raising a total of about 20.2 billion yuan. The number of issues and the scale of fund-raising decreased year-on-year. Yongxing shares, Longqi Technology, and Weihua New Materials raised a total of more than 1.5 billion yuan, with a high scale. The share price of the initial public offering of Shanghai and Shenzhen main boards rose above the issue price on the first day of listing. Among them, the share prices of Red Sifang and Qiangbang New Materials rose by over 1000% compared with the issue price on the first day of listing, with a relatively high increase. In terms of underwriters, in the first 11 months of 2024, the number of projects underwritten by CITIC Securities and Guotai Junan Securities was the highest, with 5 and 4 respectively. Judging from the scale of fundraising, the total fundraising of projects underwritten by Guotai Junan Securities and CITIC Securities exceeded 5 billion yuan, and the total fundraising of projects of Huatai United Securities and Guoxin Securities exceeded 2 billion yuan. (Xinhua Finance)Ubs keeps the rating of western oil companies neutral.Ultra-long-term Treasury ETF rose sharply at the opening, with "Boshi SSE 30-year Treasury ETF" rising by 0.65% and "Pengyang China Bond -30-year Treasury ETF" rising by 0.65%.
South Korea's stock market rebounded after its market value evaporated by $100 billion due to the political crisis. South Korea's stock market rebounded on Tuesday, which was the first rise since the martial law storm caused the country to fall into political turmoil last week. South Korea's Kospi index rose more than 2% in early trading, after its recent decline pushed it to the edge of a bear market. The Kosdaq small-cap stock index rose more than 4%. In the four trading days as of Monday, the total market value of these two index companies evaporated by $100 billion. South Korean authorities have repeatedly promised to take all measures to stabilize market sentiment, saying that the recent market trend is "excessive" considering the country's economic fundamentals. President Yin Xiyue survived the parliamentary impeachment vote over the weekend, but the opposition party vowed to continue to push him to step down.Pre-cooked food concept stocks moved higher, and Haixin Food, Tongqinglou, Qianweiyang Kitchen, Shuangta Food and Huifa Food had daily limit.The United States ITC issued a final ruling on 337 parts of products containing telpotide. According to China Trade Relief Information Network, on December 9, the United States International Trade Commission (ITC) announced that, For certain products containing tilloptide and products sourcing to contain tilloptide, The investigation code: 337-TA-1377) made a final ruling in part 337: to solicit opinions on the public interests involved in the suggested relief measures made by the administrative judge in this case on December 6, 2024. If there is infringement in this case, the suggested relief measures are (1) to issue a general exclusion order on the products involved in the US export, import and sale of infringing US registered patent numbers. (2) Or to the defendant Mew Mews Company Limited in Hong Kong, China, Audrey Beauty Co in Hong Kong, China, Spanish Super Human Store, American Triggered Supplies LLC (D/B/A The Triggered Brand), Strate Labs LLC of the United States and Xiamen Austria Trading Co., Ltd. (D/B/A Austria Propide) of China issued general or limited exclusion orders for infringing products exported, imported and sold in the United States. (3) Issue general or limited exclusion orders and prohibition orders to listed defendants: American Arctic Peptides LLC, American Triggered Supplements LLC (D/B/A The Triggered Brand) and American Strate Labs LLC.
The two departments issued a document: improve the working mechanism of centralized procurement and implementation of medicines. Recently, the National Medical Insurance Bureau and the National Health and Health Commission issued the Notice on Improving the Working Mechanism of Centralized Procurement and Implementation of Medicines. On the basis of the original policy, the Notice further improves the centralized procurement and implementation mechanism of medicines, guides medical institutions and pharmaceutical enterprises to follow and support the centralized procurement mechanism, and consolidates and deepens the reform results of centralized procurement of medicines and medical consumables, so that more patients can benefit. The "Notice" focuses on the detailed measures from the aspects of admission, use, monitoring, assessment and feedback of centralized drug consumables, which reflects the policy orientation of coordinated supervision between departments and preferential use of selected products. (CCTV News)Mao Geping opened 59.90% higher on the first day of listing, and Mao Geping opened 59.90% higher on the first day of listing. According to public information, the subscription for public offering of new shares of Hong Kong stocks in Mao Geping reached HK$ 173.814 billion, oversubscribed by 826.27 times, making it the "king of frozen capital" in the new stock market of Hong Kong stocks this year.The two departments issued a document: improve the working mechanism of centralized procurement and implementation of medicines. Recently, the National Medical Insurance Bureau and the National Health and Health Commission issued the Notice on Improving the Working Mechanism of Centralized Procurement and Implementation of Medicines. On the basis of the original policy, the Notice further improves the centralized procurement and implementation mechanism of medicines, guides medical institutions and pharmaceutical enterprises to follow and support the centralized procurement mechanism, and consolidates and deepens the reform results of centralized procurement of medicines and medical consumables, so that more patients can benefit. The "Notice" focuses on the detailed measures from the aspects of admission, use, monitoring, assessment and feedback of centralized drug consumables, which reflects the policy orientation of coordinated supervision between departments and preferential use of selected products. (CCTV News)
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13